These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
268 related items for PubMed ID: 213610
1. Development of cell-mediated immunity to Marek's disease tumor cells in chickens inoculated with Marek's disease vaccines. Sharma JM, Witter RL, Coulson BD. J Natl Cancer Inst; 1978 Nov; 61(5):1273-80. PubMed ID: 213610 [Abstract] [Full Text] [Related]
3. Cell-mediated cytotoxicity of lymphocytes from chickens inoculated with herpesvirus of turkey against a Marek's disease lymphoma cell line (MSB-1). Kitamoto N, Ikuta K, Kato S, Yamaguchi S. Biken J; 1979 Mar; 22(1):11-20. PubMed ID: 317001 [Abstract] [Full Text] [Related]
4. Dissociation of antiviral and antitumor immunity in resistance to Marek's disease. Powell PC, Rowell JG. J Natl Cancer Inst; 1977 Sep; 59(3):919-24. PubMed ID: 197249 [Abstract] [Full Text] [Related]
6. Characterization of an antigen associated with the Marek's disease lymphoblastoid cell line MSB-1. Ross LJ. J Gen Virol; 1982 Jun; 60(Pt 2):375-80. PubMed ID: 6286857 [Abstract] [Full Text] [Related]
8. Syngeneic lysis of reticuloendotheliosis virus-transformed cell lines transfected with Marek's disease virus genes by virus-specific cytotoxic T cells. Uni Z, Pratt WD, Miller MM, O'Connell PH, Schat KA. Vet Immunol Immunopathol; 1994 Dec; 44(1):57-69. PubMed ID: 7725630 [Abstract] [Full Text] [Related]
10. Targeted Deletion of Glycoprotein B Gene by CRISPR/Cas9 Nuclease Inhibits Gallid herpesvirus Type 3 in Dually Infected Marek's Disease Virus-Transformed Lymphoblastoid Cell Line MSB-1. Zhang Y, Li W, Tang N, Moffat K, Nair V, Yao Y. J Virol; 2022 Mar 23; 96(6):e0202721. PubMed ID: 35107377 [Abstract] [Full Text] [Related]
13. Marek's disease--the disease and its prevention by vaccination. Biggs PM. Br J Cancer Suppl; 1975 Mar 23; 2():152-5. PubMed ID: 170953 [Abstract] [Full Text] [Related]
14. Nature of genetic resistance to Marek's disease in chickens. Lee LF, Powell PC, Rennie M, Ross LJ, Payne LN. J Natl Cancer Inst; 1981 Apr 23; 66(4):789-96. PubMed ID: 6262555 [Abstract] [Full Text] [Related]
15. Syngeneic Marek's disease virus (MDV)-specific cell-mediated immune responses against immediate early, late, and unique MDV proteins. Omar AR, Schat KA. Virology; 1996 Aug 01; 222(1):87-99. PubMed ID: 8806490 [Abstract] [Full Text] [Related]
16. The efficacy of recombinant fowlpox vaccine protection against Marek's disease: its dependence on chicken line and B haplotype. Lee LF, Bacon LD, Yoshida S, Yanagida N, Zhang HM, Witter RL. Avian Dis; 2004 Aug 01; 48(1):129-37. PubMed ID: 15077806 [Abstract] [Full Text] [Related]
17. Demonstration of Marek's disease tumor-associated surface antigen in chickens infected with nononcogenic Marek's disease virus and herpesvirus of turkeys. Schat KA, Calnek BW. J Natl Cancer Inst; 1978 Sep 01; 61(3):855-7. PubMed ID: 211242 [Abstract] [Full Text] [Related]
18. Comparative pathogenesis studies with oncogenic and nononcogenic Marek's disease viruses and turkey herpesvirus. Calnek BW, Carlisle JC, Fabricant J, Murthy KK, Schat KA. Am J Vet Res; 1979 Apr 01; 40(4):541-8. PubMed ID: 229747 [Abstract] [Full Text] [Related]
19. Antibody directed against Marek's disease-associated tumor surface antigen can be eluted from Marek's disease tumor cells. Pradhan HK, Mohanty GC, Lee WY, Patnaik B. Vet Immunol Immunopathol; 1991 Sep 01; 29(3-4):229-38. PubMed ID: 1659032 [Abstract] [Full Text] [Related]
20. Induction of lymphomas and tumor antigen by Marek's disease virus in turkeys. Elmubarak AK, Sharma JM, Witter RL, Nazerian K, Sanger VL. Avian Dis; 1981 Sep 01; 25(4):911-26. PubMed ID: 6279077 [Abstract] [Full Text] [Related] Page: [Next] [New Search]